menu
    • menu

    Company profile for Flare Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Flare is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, Flare’s team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. ...
    Flare is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, Flare’s team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target ‘switch sites’ has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Flare TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    215 First Street., Suite 150 Cambridge, MA 02142
    Telephone
    Telephone
    857-706-4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.flaretx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/flare-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/flaretx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Flare Therapeutics Joins Piper Sandler Healthcare Conference
    Flare Therapeutics Joins Piper Sandler Healthcare Conference

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194295/0/en/Flare-Therapeutics-to-Participate-in-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Flare Therapeutics Presents FX-909 Ph1A Biomarker Analysis
    Flare Therapeutics Presents FX-909 Ph1A Biomarker Analysis

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183704/0/en/Flare-Therapeutics-Presents-Correlative-Biomarker-Analysis-from-the-FX-909-Phase-1A-Clinical-Study-at-SITC-2025-40th-Anniversary-Annual-Meeting.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Flare Therapeutics Joins November Investor Conferences
    Flare Therapeutics Joins November Investor Conferences

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179352/0/en/Flare-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-in-November.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Flare Therapeutics To Present FX-909 Phase 1a Biomarker Analysis
    Flare Therapeutics To Present FX-909 Phase 1a Biomarker Analysis

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177499/0/en/Flare-Therapeutics-to-Present-Correlative-Biomarker-Analysis-from-the-FX-909-Phase-1A-Clinical-Study-at-Upcoming-SITC-2025-40th-Anniversary-Annual-Meeting.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Flare Therapeutics Unveils FX-909 Phase 1 Study Data
    Flare Therapeutics Unveils FX-909 Phase 1 Study Data

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172983/0/en/Flare-Therapeutics-Presents-Part-A-Data-from-FX-909-Phase-1-Study-at-AACR-NCI-EORTC-International-Conference.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Flare Pharma Collaborates with Merck for Fx-909 and Keytruda
    Flare Pharma Collaborates with Merck for Fx-909 and Keytruda

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170066/0/en/Flare-Therapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Merck-to-Evaluate-FX-909-in-Combination-with-KEYTRUDA-pembrolizumab-in-New-Cohort-of-Ongoing-Pha.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search